Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Filings indexed 384 across all filing types
Latest filing 2025-04-27 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled "内部控制自我评价报告" which translates to "Internal Control Self-Evaluation Report." It discusses the company's internal control evaluation as of December 31, 2024, including detailed descriptions of internal control environment, risk assessment, control activities, and defect identification and remediation. The document is comprehensive (8099 characters) and contains substantive content about internal control effectiveness related to financial reporting and operational risks. It is not an announcement of a report publication but the report itself. This type of document aligns with an Audit Report / Information (AR) category, as it focuses on internal control evaluation and related audit-type information rather than a full annual report or other categories. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-27 Chinese
2024年度独立董事述职报告(武晓锋)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for 2024" from Shanxi Dayu Biological Engineering Co., Ltd. It details the independent director's duties, meeting attendance, committee participation, communication with auditors, and efforts to protect minority shareholders. The content is a detailed report on the independent director's activities and governance oversight during the year 2024. It is not an announcement of a report, nor a financial statement or earnings release. It is a governance-related report focusing on board and director activities, consistent with Board/Management Information filings. Therefore, the document fits best under the Board/Management Information (MANG) category.
2025-04-27 Chinese
董事会审计委员对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the company's Board Audit Committee regarding the supervision of the external audit firm (信永中和会计师事务所) for the 2024 fiscal year. It details the audit firm's qualifications, the committee's oversight activities, and an overall evaluation of the audit firm's performance. The document does not contain the full audit report or financial statements but rather focuses on the audit committee's supervisory role and assessment of the audit firm. This matches the definition of an Audit Report / Information filing, which includes standalone audit reports and information about audit processes and oversight, excluding full annual reports. The document length is 1668 characters, which is short but contains substantive content about audit supervision, not just an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2024
2025-04-27 Chinese
拟续聘2025年度会计师事务所公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the proposed reappointment of the accounting firm 信永中和会计师事务所 for the 2025 fiscal year audit services. It details the firm's background, audit fees, and the approval process by the board and audit committee. There are no actual financial statements or audit reports included, only information about the appointment and related procedures. The document length is 2664 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit services and auditor appointment, but it is not a full annual report or audit report itself. However, given the short length and nature, it could also be considered a Regulatory Filing (RNS) as a fallback. But since it specifically concerns audit firm appointment and audit fees, AR is the most appropriate classification. FY 2025
2025-04-27 Chinese
2024年度非经营性资金占用及其他关联资金往来的专项说明
Regulatory Filings
2025-04-27 Chinese
2024年年度报告摘要
Annual Report Classification · 95% confidence The document is titled '年度报告摘要 2024' which translates to 'Annual Report Summary 2024'. It contains detailed financial data for the year 2024, including assets, liabilities, net profit, earnings per share, and shareholder information. It also includes management assurances about the accuracy and completeness of the report, mentions an audit report with an unqualified opinion, and discusses company business activities and shareholder structure. The length of the document (5291 characters) and the detailed financial and operational data indicate this is the actual annual report or a substantial summary of it, not merely an announcement or a brief summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2024
2025-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.